Skip to main
NVS
NVS logo

Novartis (NVS) Earnings Dates & Reports

Novartis (NVS) Most Recent Earnings

Report DateOct 28, 2025
Period EndingQ3 2025
Est. EPS$2.29
Actual EPS$2.25
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Novartis (NVS) Earnings per Share (EPS) History

Signup for full access
Browse free

Novartis (NVS) Latest Earnings

The value each NVS share was expected to gain vs. the value each share gained.

Novartis (NVS) reported its most recent earnings on Oct 28, 2025 for Q3 2025, posting earnings per share (EPS) of $2.25. This exceeded analysts' expectations of $2.29 by 1.75%, marking a Miss.

For comparison, Novartis reported EPS of $2.06 in the same quarter last year.

The company is expected to announce its next earnings report on 01/30/2026, with analysts projecting an EPS of $2.07.

Novartis (NVS) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Jan 30, 2026
$2.07Next earnings call Jan. 30, 2026
Q3 2025Oct 28, 2025
$2.29$2.25-1.75%
Q2 2025Jul 17, 2025
$2.38$2.47+3.78%
Q1 2025Apr 29, 2025
$2.08$2.28+9.62%
Q4 2024Jan 31, 2025
$1.79$1.98+10.61%
View all

Novartis (NVS) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Novartis’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Oct 28, 2025
Jul 17, 2025
Apr 29, 2025
Jan 31, 2025

Novartis (NVS) Earnings FAQs

Novartis (NVS) last reported earnings on Oct 28, 2025 for Q3 2025, posting an EPS of $2.25, which Miss the estimate of $2.29 by 1.75%.

For Q3 2025, Novartis (NVS) reported an EPS of $2.25, missing analysts' estimate of $2.29 by 1.75%.

For Q3 2025, Novartis (NVS) Miss expectations with an actual EPS of $2.25 vs. an estimated EPS of $2.29.

Following the last earnings report on Oct 28, 2025, Novartis (NVS)'s stock price moved — from — to —.

The next Novartis (NVS) earnings call is scheduled for Jan. 30, 2026, where executives will discuss financial results and outlook.

Novartis (NVS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.